Bile Duct Cancer Market 2018 – Global Trend in Healthcare Industry by Top 10 Players Analysis and Forecasts Till 2023 | Asserts MRFR

Market Research Future published a Premium Research Report on “Global Bile Duct Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Pune, India - April 16, 2018 /MarketersMedia/ —

The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.2% during the forecast period. Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. According to the National Cancer Institute, in 2014, there were an estimated 66,771 people living with liver and intrahepatic bile duct cancer in the United States. Moreover, the disease is expected to cause 28,920 deaths by the end of 2017 accounting for 4.8% of all cancer deaths. Rates for new liver and intrahepatic bile duct cancer cases have risen by an average 2.7% each year over the last 10 years. Death rates have been estimated to have risen by an average of 2.6% each year over 2005-2014. Such an increase in the prevalence of bile duct cancer has boosted the market. Additionally, rising healthcare expenditures, increasing awareness for the disease and investments in the R&D for treatment procedures is fuelling the market further. However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected to restrain the market during the forecasted period.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4741 .

Key Players in the Bile Duct Cancer Market:

Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Isreal), Eli Lilly and Company. (U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), and others.

Bile Duct Cancer Market Regional Analysis:

The Americas dominates the global bile duct cancer market owing to a well-developed healthcare sector. Apart from this, increasing number of patients, increasing healthcare expenditure have boosted the growth of the market in the Americas. According to the Centers for Disease Control and Prevention, U.S. health care spending in 2015, reached $3.2 trillion or $9,990 per person which accounted for 17.8% of the total GDP.

Europe is the second largest bile duct cancer market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development drives the European market.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. According to Indian Brand Equity Fund, the per capita healthcare expenditure in India is estimated to grow at a CAGR of 5% during 2008-15 and reach USD 68.6 by 2015.

On the other hand, the Middle East & Africa has the least share in the global bile duct cancer market due to the presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Global Bile Duct Cancer Market Segmentation:

The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.

On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.

On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.

On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.

On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4741 .

Major TOC Bile Duct Cancer Market Research Report – Global Forecast Till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued….!

LIST OF TABLES

Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023

Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)

Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)

Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Bile Duct Cancer Market

Figure 3 Segmentation Market Dynamics For Global Bile Duct Cancer Market

Figure 4 Global Bile Duct Cancer Market Share, By Type 2016

Figure 5 Global Bile Duct Cancer Market Share, By Diagnosis 2016

Figure 6 Global Bile Duct Cancer Market Share, By Treatment 2016

Figure 7 Global Bile Duct Cancer Market Share, By End Users, 2016

Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/4741 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Market Research Future, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312

Source URL: https://marketersmedia.com/bile-duct-cancer-market-2018-global-trend-in-healthcare-industry-by-top-10-players-analysis-and-forecasts-till-2023-asserts-mrfr/331637

For more information, please visit https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741

Source: MarketersMedia

Release ID: 331637

More News From The Buzz Reporters

Producer who worked with Franklin recalls great performances

Aug 17, 2018

NEW YORK — When Ken Ehrlich, the longtime producer of the Grammys and other awards shows, worked with the Obama administration on a concert honoring women at the White House, first lady Michelle Obama laid down one rule. "You aren't doing a tribute to women in my house without Aretha Franklin," Ehrlich recalls Obama telling him. And so Franklin — a longtime friend of Ehrlich — was added to the 2014 "Women of Soul" bill, which included Patti LaBelle, Ariana Grande, Janelle Monae and Tessanne Chin. Despite those illustrious names and subsequent rousing performances, it was Franklin who of course...

Detroit residents remember Aretha Franklin, impact on city

Aug 17, 2018

DETROIT — To the rest of the world, she was the "Queen of Soul" — a woman whose strong and soulful voice could effortlessly jump multiple octaves whether belting out tear-jerking ballads or jump-and-shout gospel. To residents in her hometown of Detroit who followed her more than 50-year career, she was simply "Aretha" or more personally "Ree-Ree" — the city's favorite daughter, often singing at the Baptist church her father once led or headlining charity functions for kids or the less fortunate. "She was a pioneer woman for Detroit," said Myron Pullin, fighting back tears Thursday morning outside New Bethel...

In Franklin's anthems, women heard an empowering message

Aug 17, 2018

NEW YORK — Aretha Franklin never saw herself as a feminist heroine. That, she quipped, was Gloria Steinem's role. But she leaves a legacy of indelible anthems that resonated deeply with women by celebrating their strength and individuality — and demanding, well, just a little respect. "I don't think I was a catalyst for the women's movement," she told Rolling Stone in 2014. "Sorry. But if I were? So much the better!" The women's movement was just getting going in 1967 when Franklin took on Otis Redding's "Respect," which soon became known as an anthem both for civil rights and...

Harper drives in 3, Nationals snap skid, beat Cardinals 5-4

Aug 17, 2018

ST. LOUIS — Koda Glover rewarded his manager's faith. Bryce Harper had three hits and drove in three runs, Glover earned the save in the first opportunity since Ryan Madson was placed on the disabled list, and the Washington Nationals snapped a four-game losing streak with a 5-4 victory over the St. Louis Cardinals on Thursday night. The Nationals won for just the third time in their last 10 games and snapped the Cardinals' season-high, eight-game winning streak. "We needed a win today," Nationals manager Dave Martinez said. "Get on that plane, have a nice happy flight and come back...

Jill Janus, singer of the metal band Huntress, dies at 43

Aug 17, 2018

PORTLAND, Ore. — Jill Janus, lead singer of the heavy metal band Huntress, has died at age 43, her family and band said Thursday. Janus had long struggled with mental Illness, and killed herself outside Portland, Oregon, on Tuesday, her relatives and bandmates said in a statement released through publicist Alexandra Greenberg. Janus fronted Huntress from the group's inception in Los Angeles in 2009, singing on three full-length albums and on tours with bands including Motorhead and Lamb of God. Founding member Blake Meahl said on his Facebook page Thursday that he and Janus "spent 9 years together creating a...

Sign up now!